Agnirva Space Premier League - Expedition #31058: Crystallizing Cures: Growing Better Interleukin Proteins in Space

In the world of biomedical science, structure often holds the key to understanding function. That’s why scientists turned to the microgravity environment of the International Space Station to produce high-quality crystals of proteins like Interleukin-1Alpha, -1Beta, and their receptor antagonist.

This experiment, led by Dr. G. Scherbakov and E. Sventitski of Biopreparat, aimed to grow purer and more well-ordered crystals than what’s typically achievable on Earth. Conducted during ISS Expeditions 7 through 17, the research focused on proteins involved in inflammation and immune responses.

Why is crystal quality important? Because detailed 3D structures of these proteins are essential for drug development. In microgravity, the absence of sedimentation and convection allows crystals to grow larger and more uniformly. This provides clearer X-ray diffraction data, which in turn leads to better models of the protein's structure.

The findings can accelerate the development of treatments for diseases involving inflammation, such as arthritis, autoimmune disorders, and even certain cancers. By understanding how Interleukin-1 proteins function and interact, researchers can design targeted therapies with fewer side effects.

This study highlights how the ISS serves not just as a platform for space exploration, but as a floating lab advancing human health. Crystals grown in space might one day lead to cures developed right here on Earth.

Join the Agnirva Space Internship Program

Get certified with over 100 hours of immersive, self-paced learning in astronomy, cosmology, space technology, and climate science through the Agnirva Space Internship Program. Join, complete virtual projects, and earn a digital certificate to showcase your space fluency in interviews, resumes, and beyond.